ruxolitinib,navitoclax
novartis,incyte,abbvie
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)', 'navitoclax', 'refine trial', '#myelof']
#ash22 news: navitoclax plus ruxolitinib for patients with myelofibrosis: review of findings from the refine trial || to read the aggrego originals piece visit: #medtwitter #onctwitter #hematology #myelofibrosis #navitoclax #ruxolitinib #refinetrial 
Your source for the latest in oncology news.